Tens of millions of doses of AstraZeneca’s coronavirus vaccine are currently sitting in U.S. distribution centers. The company is awaiting results from its U.S. clinical trial before requesting emergency use authorization from the Food and Drug Administration.
Made by the British-Swedish drugmaker AstraZeneca in collaboration with Oxford University, the vaccine has been causing controversy in some European countries over fears that it has potential links to blood clots.
On Monday its rollout…
Source link
